As of 2025-05-18, the EV/EBITDA ratio of Acura Pharmaceuticals Inc (ACUR) is -1.33. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ACUR's latest enterprise value is 1.46 mil USD. ACUR's TTM EBITDA according to its financial statements is -1.10 mil USD. Dividing these 2 quantities gives us the above ACUR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-05-08 | -1.33 |
| 2025-05-06 | -1.33 |
| 2025-03-26 | -1.32 |
| 2025-03-13 | -1.32 |
| 2025-03-12 | -1.32 |
| 2025-03-10 | -1.33 |
| 2025-03-05 | -0.18 |
| 2025-03-04 | -0.18 |
| 2025-03-03 | -0.17 |
| 2025-02-25 | -0.23 |
| 2025-02-24 | -0.23 |
| 2025-02-21 | -0.23 |
| 2025-02-20 | -0.23 |
| 2025-02-19 | -0.52 |
| 2025-02-18 | -0.52 |